165 related articles for article (PubMed ID: 34563944)
1. LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia.
Du X; Liu H; Yang C; Shi X; Cao L; Zhao X; Miao Y; Zhu H; Wang L; Xu W; Li J; Fan L
Leuk Res; 2021 Nov; 110():106706. PubMed ID: 34563944
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
4. lncRNA
Yang J; Lin X; Jiang W; Wu J; Lin L
DNA Cell Biol; 2019 Sep; 38(9):1013-1021. PubMed ID: 31386568
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LEF1-AS1 promotes osteogenic differentiation of dental pulp stem cells via sponging miR-24-3p.
Wu Y; Lian K; Sun C
Mol Cell Biochem; 2020 Dec; 475(1-2):161-169. PubMed ID: 32780211
[TBL] [Abstract][Full Text] [Related]
6. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of LEF1-AS1 regulating HUVEC cells by targeting miR-489-3p/S100A11 axis.
Zhang H; Wang W; Lin J; Qiao J; Wang X; Fang B; Chen C; Wang Y; Zhu G; Liu W
PeerJ; 2023; 11():e16128. PubMed ID: 37927791
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
10. LEF1-AS1, long non-coding RNA, inhibits proliferation in myeloid malignancy.
Congrains-Castillo A; Niemann FS; Santos Duarte AS; Olalla-Saad ST
J Cell Mol Med; 2019 Apr; 23(4):3021-3025. PubMed ID: 30770626
[TBL] [Abstract][Full Text] [Related]
11. LEF1-AS1 accelerates tumorigenesis in glioma by sponging miR-489-3p to enhance HIGD1A.
Cheng Z; Wang G; Zhu W; Luo C; Guo Z
Cell Death Dis; 2020 Aug; 11(8):690. PubMed ID: 32826866
[TBL] [Abstract][Full Text] [Related]
12. LEF1-AS1 is implicated in the malignant development of glioblastoma via sponging miR-543 to upregulate EN2.
Zeng S; Zhou C; Yang DH; Xu LS; Yang HJ; Xu MH; Wang H
Brain Res; 2020 Jun; 1736():146781. PubMed ID: 32184164
[TBL] [Abstract][Full Text] [Related]
13. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA LEF1-AS1 attenuates apoptosis and inflammatory injury of microglia cells following spinal cord injury.
Cui SY; Zhang W; Cui ZM; Yi H; Xu DW; Liu W; Zhu XH
J Orthop Surg Res; 2021 Jan; 16(1):6. PubMed ID: 33407665
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/β-catenin pathway.
He H; Qin M
Clin Exp Pharmacol Physiol; 2020 May; 47(5):886-891. PubMed ID: 31990064
[TBL] [Abstract][Full Text] [Related]
16. Cancer-testis non-coding RNA LEF1-AS1 regulates the nuclear translocation of PDCD5 and suppresses its interaction with p53 signaling: a novel target for immunotherapy in esophageal squamous cell carcinoma.
Xiao Z; Si M; Cao J; Chen X; Wang Z; Zhang T; Zhou Y; Li H; Dai J; Wang C; Chen L; Xu J
Carcinogenesis; 2023 May; 44(3):263-276. PubMed ID: 36827466
[TBL] [Abstract][Full Text] [Related]
17. LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer.
Wang A; Zhao C; Gao Y; Duan G; Yang Y; Fan B; Wang X; Wang K
Invest New Drugs; 2019 Dec; 37(6):1127-1134. PubMed ID: 30734202
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
